Skip Navigation


Glycobiology Advance Access first published online on January 28, 2008
This version published online on February 18, 2008

Glycobiology, doi:10.1093/glycob/cwn002
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
18/3/270    most recent
cwn002v2
cwn002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Shaya, D.
Right arrow Articles by Cygler, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaya, D.
Right arrow Articles by Cygler, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Composite Active Site of Chondroitin Lyase ABC Accepting Both Epimers of Uronic Acid

David Shaya1, Bum-Soo Hahn2, Tonje Marita Bjerkan3, Wan Seok Kim4, Nam Young Park5, Joon-Soo Sim5, Yeong-Shik Kim5 and Miroslaw Cygler1,6,

1 Department of Biochemistry, McGill University, Montréal, Québec, Canada
2 National Institute of Agricultural Biotechnology, 225 Seodun-Dong, Suwon 441-707, South Korea
3 Department of Biotechnology, The Norwegian University of Science and Technology, Sem Sælands vei 6/8, N-7491 Trondheim, Norway
4 Division of Hematology, St. Mary's Hospital, The Catholic University of Korea, Seoul 150-713, South Korea
5 Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul 110-460, South Korea
6 Biotechnology Research Institute, NRC, 6100 Royalmount Avenue, Montréal, Québec, H4P 2R2, Canada


Correspondence to: Dr. Mirek Cygler, Biotechnology Research Institute, NRC, 6100 Royalmount Avenue, Montréal, Québec, Canada H4P 2R2, Tel: 514-496-6321, Fax: 514-496-5143, Email: mirek{at}bri.nrc.ca

Received on December 17, 2007; accepted on January 17, 2008

Enzymes have evolved as catalysts with high degrees of stereospecificity. When both enantiomers are biologically important, enzymes with two different folds usually catalyze reactions with the individual enantiomers. In rare cases a single enzyme can process both enantiomers efficiently, but no molecular basis for such catalysis has been established. The family of bacterial chondroitin lyases ABC is comprised of such enzymes. They can degrade both chondroitin sulfate (CS) and dermatan sulfate (DS) glycosaminoglycans at the non-reducing end of either glucuronic acid (CS) or its epimer iduronic acid (DS) by a β-elimination mechanism, which commences with removal of the C-5 proton from the uronic acid. Two other structural folds evolved to perform these reactions in an epimer specific fashion: ({alpha}/{alpha})5 for CS (chondroitin lyases AC) and β-helix for DS (chondroitin lyases B); their catalytic mechanisms have been established at the molecular level. The structure of chondroitinase ABC from Proteus vulgaris showed surprising similarity to chondroitinase AC, including the presence of a Tyr-His-Glu-Arg catalytic tetrad, which provided possible mechanism for CS degradation but not for DS degradation. We determined the structure of a distantly related Bacteroides thetaiotaomicron chondroitinase ABC to identify additional structurally conserved residues potentially involved in catalysis. We found a conserved cluster located ~12 Å from the catalytic tetrad. We demonstrate that a histidine in this cluster is essential for catalysis of DS but not CS. The enzyme utilizes a single substrate-binding site while having two partially overlapping active sites catalyzing the respective reactions. The spatial separation of the two sets of residues suggests a substrate-induced conformational change that brings all catalytically essential residues close together.

Key words: chondroitinase ABC / catalytic mechanism / glycosaminoglycans / crystal structure / site-directed mutagenesis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.